Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other 1Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 2Intestinal Obstruction 2Colorectal Neoplasms 2Vulvar Neoplasms 1Vomiting 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Nausea 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Diarrhea 1Constipation 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 3Trastuzumab 2Interleukin-12 Subunit p35 2Drug Therapy 2tivozanib 1tipifarnib 1spartalizumab 1seribantumab 1pertuzumab 1motexafin lutetium 1irinotecan sucrosofate 1entinostat 1atezolizumab 1Specimen Handling 1Ritonavir 1Quality of Life 1Positron Emission Tomography Computed Tomography 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Ondansetron 1Octreotide 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Mesna 1Magnetic Resonance Spectroscopy 1Leucovorin 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Octreotide × Gynecologic × Clear all
NCT00004895 2012-06-06

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Northwestern University

Phase 2 Completed
GastrointestinalGynecologicOtherSarcoma

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Colonic Neoplasms, Constipation, Intestinal Obstruction, Nausea, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡